Cough Hypersensitivity Syndrome Market Emerging Trends and Growth Drivers Through 2029 | Reach USD $14.46 Billion
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Will The Cough Hypersensitivity Syndrome Market Valuation Change Between Now And 2029?
There has been significant expansion in the market size for cough hypersensitivity syndrome in the past few years. The market which was valued at $10.36 billion in 2024, will accelerate to $10.92 billion in 2025, showing a compound annual growth rate (CAGR) of 5.4%. The growth observed in the historic period can be ascribed to factors such as raised awareness, the adoption of telemedicine and remote monitoring, public health schemes, and funding for research.
The market size of cough hypersensitivity syndrome is anticipated to experience significant expansion in the coming years. The market is projected to surge to a value of $14.46 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.3%. The expected growth during the forecast period is deemed to be a result of improved global health access, support for patient advocacy, and enhanced quality of life. The key trends during the forecast period involve advancement in diagnosis and screening tools, customized treatment methods, and introduction of new medications.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12989&type=smp
What Growth-Enabling Forces Are Impacting The Cough Hypersensitivity Syndrome Market?
The escalating occurrence of chronic respiratory diseases is projected to boost the advancement of the cough hypersensitivity syndrome market in the future. Chronic respiratory diseases, commonly known as CRDs, are a collection of enduring diseases that impact the airways and lungs, resulting in continuous breathing issues and a decrease in lung function over an extended period. Treatments for cough hypersensitivity syndrome can alleviate discomfort, bolster respiratory health, and subsequently enhance the lives of those suffering from chronic respiratory diseases like asthma. For example, in June 2023, the Australian Institute of Health and Welfare, an agency based in Australia, noted that nearly a third (30%) of Australians, equating to about 7.5 million people, have chronic respiratory diseases. What’s more, as stated in May 2024 by the National Center for Health Statistics (NCHS), a health statistics agency based in the U.S, the rates of current asthma among American adults aged 18 and above rose from 8.4% in 2021 to 8.7% in 2022. Additionally, the frequency of asthma instances among adults within the same age group increased from 3.3% in 2021 to 3.7% in 2022. As a result, the escalating occurrence of chronic respiratory diseases triggers growth in the cough hypersensitivity syndrome market.
What Are The Main Segment Classifications In The Cough Hypersensitivity Syndrome Market?
The cough hypersensitivity syndromemarket covered in this report is segmented –
1) By Drug Class: Inhales Corticosteroids; Antitussive Agents; Short-acting Beta-2 Agonists; Anticholinergics; Proton Pump Inhibitors; Antihistamines; Other Drugs
2) By Route of Administration: Oral; Inhalation; Other Route Of Administration
3) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Inhaled Corticosteroids: Budesonide; Fluticasone; Beclomethasone
2) By Antitussive Agents: Dextromethorphan; Codeine; Benzonatate
3) By Short-acting Beta-2 Agonists: Albuterol; Levalbuterol
4) By Anticholinergics: Ipratropium Bromide; Tiotropium
5) By Proton Pump Inhibitors: Omeprazole; Esomeprazole; Lansoprazole
6) By Antihistamines: Cetirizine; Loratadine; Diphenhydramine
7) By Other Drugs: Mucolytics; Combination Therapy Drugs
Which Emerging Trends Are Reshaping The Cough Hypersensitivity Syndrome Market Landscape?
Leading firms in the cough hypersensitivity syndrome market are striving to revolutionize asthma treatments, such as asthma rescue inhalers, to optimize patient results and ameliorate overall life quality. Asthma rescue inhalers, compact gadgets that dispense quick-relief medication to open the airways speedily, could potentially assuage abrupt coughing incidents by providing transient relief from cough-induced airway blockage and reducing airway sensitivity. In April 2024, for example, Teva Pharmaceutical Industries Ltd, a pharmaceutical company located in Israel, entered into a collaboration with Launch Therapeutics, a clinical development company in the United States. The goal of this partnership is to fast-track the clinical research program for its ICS-SABA (inhaled corticosteroid and short-acting beta-agonist) inhaler, TEV-‘248, which contains both fluticasone propionate and albuterol sulfate, and is intended for both adult and pediatric asthma patients. Moreover, it aspires to decrease dependence on generics.
Which Firms Are Driving Innovation Within The Cough Hypersensitivity Syndrome Market?
Major companies operating in the cough hypersensitivity syndrome market are Pfizer Inc., Johnson and Johnson Ltd., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck and Co Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Wyeth Pharmaceuticals Inc., AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Mylan N.V., Lupin Limited, Cadila Pharmaceuticals, Almirall S.A., Akorn Operating Company LLC, Kudco Ireland Ltd., Prestige Consumer Healthcare Inc., GMP Laboratories of America Inc., The Betty Mills Company, Acura Pharmaceuticals Inc.
Access The Complete Report Here:
What Are The Emerging Regional Trends Driving The Cough Hypersensitivity Syndrome Market?
North America was the largest region in the cough hypersensitivity syndrome market in 2024. The regions covered in cough hypersensitivity syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12989&type=smp
Browse Through More Reports Similar to the Global Cough Hypersensitivity Syndrome Market 2025, By The Business Research Company
Cough And Cold Preparations Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cough-and-cold-preparations-global-market-report
Chronic Cough Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report
Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
